Trial intelligence / Profile preview

Magnesium sulfate in mechanically ventilated multiple trauma patients

IRCT20230719058853N1Phase 3Completed

Sponsor
Vice-Chancellery for Research, Hormozgan University of Medical Sciences
Start
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of magnesium sulfate in polytrauma (2 arms), sponsored by Vice-Chancellery for Research, Hormozgan University of Medical Sciences. Primary endpoints: Blood pressure, Oxygen saturation and 4 more. Started Aug 2023; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

polytrauma

Beyond the preview

Go deeper on IRCT20230719058853N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230719058853N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call